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Little numerical analysis has been done on fluorescence lifetime imag-
ing in-vivo. Here, a 3D fluorescence Monte Carlo model is used to evaluate
a microvasculature geometry obtained via two-photon microscopy. I found
that a bulk-vascularization assumption does not provide an accurate picture
of penetration depth of the collected fluorescence signal. Instead the degree of
absorption difference between extravascular and intravascular space, as well as
the absorption difference between excitation and emission wavelengths must be
taken into account to determine the depth distribution. Additionally, I found
that using targeted illumination can provide for superior surface vessel sensi-
tivity over wide-field illumination, with small area detection offering an even
greater amount of sensitivity to surface vasculature. Depth sensitivity can be
enhanced by either increasing the detector area or increasing the illumination
area. Finally, it is shown that the excitation wavelength and vessel size can
affect intra-vessel sampling distribution, as well as the amount of signal that
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Fluorescence imaging is a widely used method of measuring functional
and structural parameters which cannot be easily imaged using endogenous
chromophores. The specific uses of fluorophores and phosphors in-vivo vary
widely; a few examples include applications such as molecular imaging, cancer
imaging, and functional imaging of hemodynamic properties [16]. Correspond-
ingly, there are a number of delivery methods for fluorophores depending on
the application in question.
Several imaging methods require the topical application of fluorophores,
and subsequent diffusion through the tissue prior to imaging. An example of
this method is voltage sensitive dye (VSD) imaging, which is often used to
study neuronal firing by measuring calcium flux into and out of cells [5]. When
not considering the genetically expressed protein variants, These methods are
inherently limited by both the capability of the fluorophore to diffuse through
the tissue, and the need to excite the fluorophore and measure the emission
through the highly turbid tissue media. However, as these agents distribute
themselves in the tissue via diffusion, predicting the distribution of the agent
in the tissue can typically be done through the diffusion equation.
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Intravascular contrast agents do not suffer from the need to diffuse
through tissue. However, imaging is more difficult to model mathematically
as the fluorophore is no longer distributed in a smooth gradient, as is generally
the assumption in VSD imaging. Several analytical methods have been used
to model photon migration in an intravascular fluorescence imaging context.
All of these methods treat the tissue as a homogeneous medium, or a series
of homogeneous layers, where diffusion determines the depth and resolution
of imaging [2, 9, 23]. In the brain, these methods fail to consider the wide
variance in absorption between the intra- and extra-vascular space.
The purpose of this work is to analyze two common intravascular con-
trast agents used to measure hemodynamic parameters in the brain: porphyrin
and Indocyanine Green (ICG). Porphyrin-based contrast agents are oxygen
sensitive phosphorescent probes which have excitation maximums at 415 and
524nm, and an emission maximum at 690nm. ICG is a fluorescent probe used
to image blood flow and clearance, and has an absorption maximum in plasma
at approximately 800nm, and an emission maximum at 880nm. The dyes were
chosen so that several situations could be studied: visible wavelength excita-
tion with NIR emission, and NIR excitation with NIR emission.
Optical in-vivo pO2 measurements using oxygen-sensitive contrast agents
have recently become a popular method for evaluating physiological and dis-
ease models [1, 8, 11, 13, 22]. Optical imaging of pO2 in-vivo has the advantage
of having both high spatial resolution and high temporal resolution [31].
Fluorescence and phosphorescence imaging [18, 22, 26] in-vivo can be
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broadly classified based on the method of excitation: single photon methods
[1, 8, 15, 20, 23, 25, 27, 31] rely on diffusion of light into tissue to generate probe
emission, while two photon methods allow for depth-selected excitation at a
point inside the tissue [6, 19]. Single photon imaging can be further classified
into methods that use targeted excitation [15, 31], and methods that use wide-
field illumination [23].
Several methods have been developed to ensure that excitation is lo-
calized, including using scanning confocal microscopy [31] and a Digital Mi-
cromirror Device (DMD)[15]. The confocal system also confines the photons
detected to a small area in the tissue, while the DMD system integrates the
photons emitted from a large area on the tissue surface.
A model has been developed whereby fluorescence and phosphorescence
emission can be modeled in a realistic in-vivo geometry using excitation and
detection schemes currently being used[15, 24, 30]. The model is used to de-
termine the differences in phosphorescence emission distribution between a
realistic microvasculature geometry and bulk tissue geometry. The model is
further used to demonstrate the intra-vascular distribution of phosphorescence
emission based on the excitation wavelength. The in-vivo geometry is acquired
through the use of two-photon microscopy. The theory behind two-photon mi-
croscopy, as well as the properties which make it especially suited to providing
tissue geometry files for Monte Carlo simulation, are presented later in this
work.
The model uses a 3D fluorescence Monte Carlo method to evaluate
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an illumination and detection scheme in an arbitrary geometry[10, 12]. Simi-
lar non-fluorescence based techniques [14] have been used to study port-wine
stain in an epidermal geometry obtained via optical coherence tomography[3].
Geometries are specified by setting tissue optical properties in a 3D voxelized
grid. Optical properties for each voxel can be specified for both the excitation
light and the emitted light. The modeled excitation photons scatters through
the tissue and can either be absorbed in a voxel, whereby an emission event
may occur, or terminated if it reaches the boundary of the geometry. Emission
photons originate from the location of absorption and are generated moving at
random angles. The emission photons can then either scatter or be absorbed
based on an independent set of emission optical properties. The theory and
details of the Monte Carlo model are presented in detail in the next chapter.
4
Chapter 2
Three dimensional fluorescence Monte Carlo
model
The Monte Carlo model used in this work is a 3D voxelized grid method
with fluorescence simulation capabilities. The code was originally adapted
from Monte Carlo Multiple Layer (MCML) code, which was developed by
Wang and Jaques in 1995 [28] and written in ANSI standard C. The Monte
Carlo model simulates the random propagation of photons through an arbi-
trary geometry with arbirtary optical properties by sampling the step size,
scattering, and absorption through the tissue by sampling the appropriate dis-
tributions. When a sufficient number of these photons have been simulated,
the result is a convergent distribution of photon propagation through tissue.
This chapter explains the geometries that the 3D Monte Carlo model is able
to use, as well as how photons are propagated through the geometry.
2.1 Model Geometry
Our 3D Monte Carlo adaptation uses a 3D voxelized grid where the
tissue optical properties can be set independently in each voxel. This allows for
a 3D variable resolution model of tissue that can be used to emulate true tissue
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geometries. In the scope of this work, a 3D stack of two-photon fluorescence
microscopy images were processed and converted to a geometry usable with
the fluorescence Monte Carlo model.
Specifically, the geometry is stored in memory as a 3D array of charac-
ters, each of which is 8 bits. Each character is a number from 0 to 255, which
specifies the tissue type contained in the voxel corresponding to the location in
the array. Optical properties are specified by the user in the input file to the
program, so when the simulation needs to look up the properties, it uses the
tissue type number in the geometry matrix to look up the optical properties.
Several parameters are specified in the optical properties for each voxel.
First, the absorption, scattering and anisotropy is specified for the photons
entering the geometry. Another set of optical properties are also set for each
voxel, which adds the capability to model fluorescence emission. For the emis-
sion optical properties, the scattering and absorption is set based on the wave-
length of the fluorescence emission, as well as the quantum efficiency (QE).
The QE determines the propability of a fluorescence emission event given an
absorption in each voxel. In areas where there are no fluorescent molecules,
the QE value is set to 0 to represent the lack of fluorescing capabilities in that
region.
2.2 Photon simulation
The 3D Monte Carlo algorithm is outlined in Fig 2.1. First, a photon
is generated at the top of the geometry at a user specified place. The location
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at which the photon enters the tissue is determined by a specified numerical
aperture and the focal distance from the top of the geometry. The beam
radius is calculated from those parameters, and an entrance point is randomly
generated either according to a gaussian or flat, “top hat”, distribution around
the center of the illumination region. The angle at which the photon enters
the tissue is determined by a line drawn from the focal point to the entrance
point, and is stored as the cosine of the angle in the x, y, and z directions.
2.2.1 Photon step size
The intialized photon is then moved in the direction specified by the
directional cosines on a number of mean free paths, s, into the tissue. The
distance the photon travels into the tissue is referred to as the step size, and
is sampled from an exponential distribution according to Beer’s law, as seen
in Eq. 2.1, where µt represents the total attenuation coefficient, which is the
sum of the absorption, µa, and scattering, mus, coefficients in the tissue.
P (s ≥ s1) = e
−µts1 (2.1)
To generate a step size, first a uniform random number over [0,1], ξ,
is sampled using a psuedo random number generator. Eq. 2.2 is then used
to convert from a uniform distribution given by the psuedo random number
generator to an exponential distribution governed by Beer’s law.
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2.2.2 Voxel boundary interaction
Once s has been determined, the distance to the nearest voxel boundary
is calculated. If the distance to the boundary is less than the distance the
photon travels, the photon is moved to the boundary, and the distance moved is
subtracted from s. This is done so that if a different tissue type is present in the
adjacent voxel, the remaining step size can be recalculated based on the optical
properties in the new voxel. Once the remaining s has been calculated for the
new voxel, the distance to the next boundary is calculated and compared to
the step size remaining. If the photon will hit the boundary, it is moved there
as before and s is recalculated. If it does not hit a boundary, the photon is
moved the remainder of the distance s to it’s new location.
2.2.3 Scattering
When the photon arrives at the new location specified by s, scattering
and absorption events occur. Scattering is calculated in both the θ and φ di-
rections in the spherical coordinate system originating at the photon location.
In the θ direction, the scattering angle is determined by the Henyey-Green
scattering function, Eq. 2.3. The value, g, represents the anisotropy of the
scattering, a value near 1 represents almost completely forward scattering, -1
represents backward scattering, and 0 represents isotropic scattering. In tissue,
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for example, the anisotropy value is generally close to 1. In the φ direction,
the photon has an equal probability of scattering in all directions.
p(cosθ) =
1− g2
2(1− g2 − 2gcosθ)
(2.3)
Two uniformly sampled random numbers, ξ1 and ξ2, are used to deter-
mine the θ and φ directions of the scattering in each event. Eq. 2.4 represents
the conversion from the uniform distribution given by ξ1 to the distribution
governed by the Henyey-Greenstein scattering function. Eq. 2.5 represents the
transform from a uniform distribution over the range [0,1] to the range [0,2π],





{1 + g2 − [ 1−g
2
1−g−2gξ1
]} if g 6= 0
2ξ1 − 1 if g = 0
(2.4)
φ = 2πξ2 (2.5)
2.2.4 Absorption and fluorescent photon emission
In this model absorption is initially treated as an all or nothing event.
If a photon is absorbed in the tissue, then there is a probability, the quan-
tum efficiency (QE), that an emission photon will be generated. When this
happens, the optical properties of the tissue geometry change to the optical
properties of the tissue at the emission wavelength. The effect of an emitted
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photon is created by changing the anisotropy value, g, from Eqn 2.3, to 0. This
represents an isotropic scattering angle–which properly simulates the isotropic
emission from a fluorescent molecule. Once the isotropic scattering angle has
been calculated, g is set to the value that corresponds to the tissue properties
at the emission wavelength.
When the fluorescent photon is generated, the Monte Carlo simulation
also stops using µt to calculate the photon step size. Instead, the µt in Eq.
2.2 is replaced by the scattering coefficient, µs. The advantage of doing this
is that the absorption can be evaluated later in the post processing step. In
many cases, the scattering of a tissue volume does not change greatly as the
wavelength is changed. If the absorption can be done in post-processing, then
just one initial simulation can be used to generate results for a number of
different emission wavelengths, thereby saving a great deal of computational
time. This method has been exploited previously to increase the computational
efficiency of solving inverse problems using Monte Carlo simulations [10, 21].
2.2.5 Photon detection
Initially, the user also sets a center location, radius, and numerical
aperture of the area where the photons are detected. Photons which exit the
tissue at the top of the geometry, and fall within the guidelines specified by the
detector, are flagged to be stored. Photons which exit the tissue outside the
detector area are killed and not stored. Upon detection, the entire photon his-
tory, including the positions, scattering angles, the distance traveled through
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each tissue type, and origin of the fluorescence absorption event, are parsed.
As it is not feasible for limited storage reasons to store all of the movement of
every photon in the simulation, the user specifies a subset of the history data
to be stored for postprocessing.
2.3 Postprocessing
In the postprocessing phase, the Beer’s law absorption of the emitted
photon must be taken into account. While absorption of the incident excitation
photons is treated as an all-or-nothing event, the emission photons must be
weighted based on the distance they travel through each tissue in the geometry.
The contribution to the detected signal from fluorescent photons originating
at a point inside the tissue (x,y,z) is calculated as:








Where j represents the photons originating at point (x,y,z) in the tissue,
and i represents the tissue type inside the geometry. The distance each photon
travels within each tissue type, lij, is used, along with the absorption coefficient
µia in each tissue type, to generate the weight of each photon by Beer’s law.
This process is repeated for every point inside the geometry to build up a three
dimensional distribution of signal using photons that arrive at a user specified
detector location.
The depth-dependent, f(z), and depth-integrated, F (z) signal distri-
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butions, representing the depth profile of the fluorescence signals can also be
calculated. f(z), which is the probability of the collected signal originating
from a depth z in the geometry, is calculated from the signal intensity distri-







F (z) can then be calculated by integrating f(z) from 0 to z, as in Eq.








Model geometry and optical properties
In this chapter, the geometry used in all the simulations performed in
this work, as well as the optical properties of the tissue at the wavelengths of
interest, are given.
The optical properties of porphyrin and ICG were used in the model.
The Monte Carlo model allowed for an arbitrary 3D voxelized geometry, where
each voxel could represent one of up to 255 different sets of optical properties
(µa, µ
′
s, g). Quantum efficiency can be set for the emission optical properties,
which determines the likelihood of phosphorescence emission upon absorption
of an incident excitation photon.
3.1 Three dimensional two-photon geometry
3.1.1 Two photon microscopy
Two-photon fluorescence microscopy utilizes a long-wavelength excita-
tion photon to generate spatially localized fluorescence. The caveat, however,
is that by using the longer wavelength, which in two-photon microscopy is
twice as long and has half the energy of the normal excitation wavelength, two
photons must be absorbed by a fluorescent molecule nearly simulatenously in
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order to move an electron to a higher energy state. Due to this property, a
very high intensity, short pulsed beam must be focused down to a small area.
This temporal and spatial concentration of photons increases the probability
of a two-photon event occuring, and also inherantly allows for three dimen-
sional imaging. By scanning a focused beam in the x, y and z directions, a 3D
mapping of the fluorophores can be obtained.
Though modeling two-photon fluorescence imaging was not my objec-
tive, it nevertheless is a useful tool for generating models of tissue that can be
used as a geometry in which the photons may propagate in the Monte Carlo
simulation.
3.1.2 Geometry
3.1.2.1 Two-photon image acquisition
Scanning two-photon microscopy was used to generate depth resolved
stacks of microvasculature in a mouse (CD-1; male, 25.30 g). All experi-
mental procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Texas at Austin. The animals were
anesthetized by inhalation of 2.3% isoflurane in oxygen through a nose cone.
Body temperature was maintained at 37◦ C using a feedback controlled heating
plate (ATC100, World Percision Instruments, Sarasota, FL, USA) during the
experiment. The animals were fixed in a stereotaxic frame (Kopf Instruments,
Tujunga, CA, USA) and an 3mm x 3mm portion of the skull was removed
using a dental burr (IdealTM Micro-Drill, Fine Science tools, Foster City, CA,
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USA). 50µL of 5% weight/volume Texas Red (Invitrogen, Eugene, OR, USA)
was administered through a retro-orbital injection. A 500µm x 500µm image
with a resolution of 1µm was taken in 2µm z-steps down to 400µm. Fig. 3.1
shows the two-photon stack used to generate the geometry.
3.1.2.2 Geometry creation
The geometry for the Monte Carlo model was then created by filtering
the images to smooth out heterogeneities in the vasculature. The smoothing
procedure was performed in order to remove the noise present in the image
due to the two-photon instrumentation.
As the x-y resolution was 1µm, and each image represented a tissue
section 2µm deeper into the tissue; interpolation was performed in order to
create equal resolution in the x, y and z directions. A spline interpolation was
performed between each image stacks to generate an image representing the
tissue corresponding to 1µm depth intervals. Note that these images do not
necessarily represent the true tissue, but this was nevertheless necessary as the
Monte Carlo simulation requires cubic voxels to be used to create a geometry
file, and a smooth interpolation was considered to be better than filling the
middle layers with a duplicate of either of the adjacent images.
The images were then thresholded to remove the intensity mapping
and create binary images representing “vasculature” or “no vasculature.” The
binary images were then converted to a geometry file by creating a 3D matrix of
the images. Optical properties representing the intravascular and extravascular
16
Figure 3.1: 500µm by 500µm by 400µmmicrovasculature image stack acquired
by two-photon scanning microscopy.
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space were assigned to the appropriate sections of the 3D matrix.
3.1.3 Optical properties
The intravascular absorption coefficients were generated based on the
extinction coefficients of hemoglobin and porphyrin/ICG. Concentration of
hemoglobin and porphyrin in the vasculature were assumed to be 150mg/ml[17]
and 0.3 mg/ml[15] respectively. The concentration of ICG was 0.1 mg/ml.
Scattering coefficients were interpolated from NIR optical property measure-
ments performed by Bevilacqua et al [4] and integrating sphere measurements
by Friebel et al[7]. Extravascular absorption and scattering coefficients were
based on the in vitro integrating sphere measurements by Yaroslavsky et al[29].
It was necessary to use in vitro measurements of the extravascular tissue be-
cause blood was assumed to only be present in intravascular space. The in
vitro measurements were taken in the absence of blood. The quantum effi-
ciency was set to 1 for the intravascular space and 0 for the extravascular
space. Though realistically the quantum efficiency would be a small fraction
of the absorbed photons, the model allowed for 100% conversion of absorbed
excitation photons to emission photons to increase computational efficiency.
This simplification is valid because the goal is to predict spatial distribution
and relative intensity, not absolute intensity. Table 3.1 shows the optical prop-
erties used for the microvasculature geometry.
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Intravascular 280 180 0.98
Extravascular 0.5 14 0.9
524nm
Intravascular 16.3 120 0.98
Extravascular 0.1 11.3 0.9
690nm
Intravascular 0.2 100 0.98
Extravascular 0.1 10 0.9
ICG
800nm
Intravascular 3.75 124 0.98
Extravascular 0.1 12.4 0.9
880nm
Intravascular 0.7 130 0.98
Extravascular 0.1 13 0.9
3.2 Homogeneous tissue geometry
Homogeneous tissue geometries were also created to compare against
the realistic geometry. These geometries were created by using a 500x500x400
voxel geometry wherein all voxels were assigned the same properties. Optical
properties were assigned by assuming that the only absorber was blood mixed
with porphyrin, the same assumption made for the intravascular properties in
the microvasculature geometry. The properties were then scaled by 0.01, 0.05
and 0.10 to represent a bulk-vascularization assumption of 1%, 5% and 10%
respectively. The optical properties in detail may be found in Tables 3.2, 3.3
19
and 3.4.





415nm 2.8 14 0.9
524nm 0.163 11.3 0.9
690nm 0.001 10 0.9
ICG
800nm 0.0375 12.4 0.9
880nm 0.007 13 0.9





415nm 14 14 0.9
524nm 0.815 11.3 0.9
690nm 0.01 10 0.9
ICG
800nm 0.287 12.4 0.9
880nm 0.035 13 0.9
3.3 Single vessel geometry
Additional geometries were created to determine the effect of targeting
a single vessel. A 3mm x 3mm x 3mm cubic geometry with a single vessel
running down the top center was created. The size of the vessel was varied
from 25µm to 200µm in 25µm increments. The optical properties were set
according to the values found in Table 3.5. Outside the vessel, the tissue was
assumed to be homogeneous with a bulk volume fraction of approximately
20




Porphyrin 28 14 0.9
524nm 1.63 11.3 0.9
690nm 0.02 10 0.9
ICG
800nm 0.375 12.4 0.9
880nm 0.07 13 0.9
5%. Fig. 3.2 shows an example single vessel geometry, where the geometry is
collapsed along the dimension of the vessel.
21






Intravascular 280 180 0.98 -
Extravascular 14 14 0.9 -
524nm
Intravascular 16.3 120 0.98 -
Extravascular 0.815 11.3 0.9 -
690nm
Intravascular 0.2 100 0.98 1
Extravascular 0.01 10 0.9 0
ICG
800nm
Intravascular 3.75 124 0.98 -
Extravascular 0.287 12.4 0.9 -
880nm
Intravascular 0.7 130 0.98 1
Extravascular 0.035 13 0.9 0
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Figure 3.2: Geometry file used for single vessel simulations. The 3D matrix of
values is integrated along the y dimension to provide an easier viewing angle.
The square at the top-center of the geometry represents the vessel.
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Chapter 4
Accuracy of the bulk-vascularized tissue
assumption
The first consideration of this work was to analyze the difference in
the origin of emission between an in vivo microvasculature geometry, and the
more typically used assumption of homogeneous tissue with a volume fraction
of absorbers. First, the simulations used to determine the accuracy of the
homogeneous tissue assumption will be presented, followed by the results and
a discussion of their implications.
4.1 Simulations
In the microvasculature geometry, a widefield illumination and small
detection method were simulated. A 400µm diameter, slightly diverging (NA
= 0.01) cone of light was used as the illumination. The detector was a 50µm
x 50µm square at the top-center of the geometry. Imaging techniques which
rely on a full surface illumination and a camera for detection operate on a
similar principle. The small detection volume can be thought of as a single
pixel in a camera. This illumination and detection scheme will henceforth be
referred to as the “camera” scheme.
24
For each of the three homogeneous tissue geometries, 1%, 5%, and 10%
blood volume fraction, simulations were performed using 415nm and 524nm
excitation wavelengths. As with the microvasculature geometries, a wide-field
illumination method with a small area detector was used. f(z) and F (z) were
calculated from the signal distribution, Id(x, y, z) using Eqns. 2.7 and 2.8, and
used to compare the homogeneous and microvascular geometries.
4.2 Results and Discussion
The comparison between the microvasculature geometry and the ho-
mogeneous tissue geometry can be seen in Fig. 4.1. The left column of Fig.
4.1 shows the depth-dependent signal distribution, f(z), of the collected signal
distribution, calculated using Eq. 2.7. The right column of Fig. 4.1 shows the
depth-integrated signal distribution, F (z), of the collected signal as a function
of depth–a value of 0.3 at 100µm, therefore, would mean that 30% of the
fluorescence signal originated from the top 100µm of the geometry.
For reference, measurements of the volume of the microvasculature ge-
ometry showed that the approximate volume fraction of blood vessels was
3.5%. Homogenous geometries of 1%, 5%, and 10% for 415nm and 524nm
excitation and 5% and 10% for 800nm excitation are shown to demonstrate
that the results do not match a realistic geometry in most cases. The results
suggest that the accuracy of a bulk-vascularized tissue assumption is strongly
dependent on the excitation wavelength of the fluorophore.
The 415nm excitation case shown in Fig. 4.1(a) shows that the homo-
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genenous tissue assumption significantly underestimates the depth from which
the collected signal originates. Even a 1% vascularized assumption shows 90%
of the signal originating from the first 100µm, whereas the simulation shows
that 90% of the signal comes from the first 250µm. Differences in signal dis-
tribution can be attributed to the large difference between the intra and extra
vascular absorption coefficients. Fig. 5.1(a) shows that a significant portion of
hte signal fromes from surface vasculature over the illumination area and the
first vessel below the detector, at 40µm below the tissue. Excitation photons
experience a small amount of absorption outside of the blood vessels, which
allows them to scatter around blood vessels and penetrate deeper into the tis-
sue. The emission photons, being Stokes-shifted into the near infrared region,
are not strongly absorbed in any tissue and can return to the surface without
much attenuation from absorption.
524nm and 800nm excitation produced very different results. Fig.
4.1(c-d) shows that with 524nm excitation the microvasculature geometry sim-
ulation gives a depth-dependent signal distribution less than that of even a
10% vacularized homogeneous tissue geometry. While the 524nm excitation
case still shows shallower penetration than would be expected given the 3.5%
vascularized geometry used, the error is less dramatic than the 800nm case.
800nm excitation with 880nm emission, shown in Fig. 4.1(e-f) again produced
the opposite result from the 415nm excitation, where the depth penetration
is significantly less than what would be expected. 1% vacularization was not
shown, as 90% of the signal originated from the first 7-8cm, which is far deeper
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than the approximately 400µm depth penetration exhibited by the photons in
the microvasculature geometry.
Based on the results, it appears that the depth penetration in a re-
alistic geometry relative to the homogenous geometry assumption strongly
correlates with the amount of difference between the absorption of blood and
contrast agent at the excitation wavelength and the emission wavelength. A
large excitation-emission absorption difference, such as the 415nm to 690nm
in porphyrin, causes the depth of penetration to be greater than what the
homogeneous assumption would predict. A smaller difference, on the other
hand, appeared to produce the opposite effect, with the homogeneous tissue
assumption significantly overpredicting the depth of the collected signal dis-
tribution.
4.3 Conclusion
Here, I show that using a homogeneous geometry assumption to ap-
proximate the depth-distribution of the collected fluorescence signal is not an
accurate method. A more complex model, involving both the difference in
blood absorption at the excitation and emission wavelengths, as well as the
difference in absorption coefficients in the fluorescing region compared to the





































































































Figure 4.1: PDF and CDF of collected signal using homogenous, bulk-
vascularized tissue assumption and comparison to wide-field illumination with
small area detection using (a-b) 415nm, (c-d) 524nm and (e-f) 800nm excita-
tion. Note that the x-axis in (a-b) is different from (c-f).
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Chapter 5
Evaluation of illumination and detection
schemes
5.1 Simulations
For each excitation wavelength (415nm, 524nm and 800nm) the mi-
crovascular geometry was used for three illumination and detection schemes.
The “camera” illumination and detection scheme described previously was
used for the comparison, in addition to two other methods referred to as the
“targeted” method and the “confocal” method.
The second method consisted of a 20µm diameter illumination area
and a detector which captured all emission photons exiting the surface of
the tissue. This scheme mimics selective illumination of a small area of the
tissue and integration of all fluorescent photons exiting the tissue, similar to
approaches that utilize structured excitation with single point detectors[15].
This scheme will be referred to as the “targeted” illumination and detection
scheme.
The third method was a hybrid of the previous two, which is similar to
the scanning confocal method. The illumination source was a 20µm diameter
beam with an NA of 0.01, while the detector was a 50µm x 50µm square at the
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top-center of the geometry. This method is similar to the results provided when
the laser scanning confocal method[31] is used, and as such will be referred to
as the “confocal” scheme.
The results of the three illumination schemes were then compared to de-
termine the effect of choosing a targeted illumination scheme over a wide-field
illumination scheme, as well as a wide field detector (i.e. PMT or APD) over
a point detector (i.e. camera pixel) based on the desired signal distribution.
To provide a comparison between the schemes, both the depth-dependent
and depth-integrated signal distributions for each excitation and emission
wavelength pair were calculated according to Eqns. 2.7 and 2.8. Additionally,
the 3D rendering of the signal distribution for the camera scheme, Id(x, y, z),
was generated to demonstrate the effects of using a widefield illumination
method.
5.2 Results and Discussion
Figure 5.1 shows the depth dependence of the detected signals for the
three imaging geometries. Fig. 5.1(a) shows the depth-dependent signal distri-
bution, f(z), in the microvasculature geometry using the camera illumination
and detection scheme at 415nm, 524nm and 800nm excitation. Fig. 5.1(c)
shows f(z) when using a wide-field illumination method with a small detec-
tion area on the surface of the tissue, and Fig. 5.1(e) shows f(z) in the case
of the confocal illumination and detection scheme. Figs. 5.1(b), 5.1(d) and
5.1(f), on the right column, show the depth-integrated signal distribution,
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F(z), at each depth in the tissue under the illumination and detection scheme
corresponding to Figs. 5.1(a), 5.1(c) and 5.1(e).
The depth-dependent signal distribution plots represent the probability
of the collected fluorescent photons originating from each depth in the tissue.
From Fig. 5.1(a), there is approximately 0% probability of photons originating
from 100µm into the tissue, while there is a 0.5% chance of photons originat-
ing from 100µm into the tissue in the 1% and microvasculature geometries.
The depth-integrated plots, on the other hand, represent the total amount of
fluorescence originating from above a depth, zµm, in the tissue. In Fig. 5.1(b),
for example, 50% of collected fluorescence originates from the first 5-10µm in
the 5% and 10% homogeneous tissues, about 25µm in the 1% homogeneneous
tissue, and the first 100µm in the realistic in vivo microvasculature geometry.
Given the results, it is clear that the best spatial localization is obtained
when using the confocal illumination and detection scheme. The strong peak
at approximately 40µm represents an approximately 20µmwide vessel directly
below the surface position of the illumination beam. This shows that given
a low numerical aperture (NA) beam, surface vasculature can be strongly
emphasized by localizing both the illumination and the detection positions.
Using targeted or point illumination with a wide-area detector gener-
ates a strongly wavelength-dependent signal distribution. When using 415nm
excitation, the signal distribution is similar to the distribution obtained when
using the confocal scheme. However, when 524nm or 800nm excitation light
is used, the first vessel encountered did not represent a significant fraction
31
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Figure 5.1: (a) Depth-dependent (f(z)) and (b) depth-integrated (F (z)) signal
distribution for the targeted illumination and detection scheme; (c) and (d)
are f(z) and F (z) using the camera scheme, and (e) and (f) are f(z) and F (z)
using the confocal scheme.
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of the total measured signal. This observation could be useful in selecting a
wavelength for excitation, depending on the goal or target of imaging. With
porphyrin, for example, either the surface vasculature can be emphasized by
using 415nm excitation light, or higher depth sensitivity can be obtained by
using 524nm excitation light.
Lastly, the camera scheme shown in Fig. 5.1(c-d), is the least sensitive
method of the three to surface vasculature, with only a small fraction of the
total collected signal originating from directly under the detector area. Re-
gardless of the excitation wavelength used, the light entering the detector is
not representative of the surface vasculature below the detector area. This is
an important observation, as often the surface vasculature will be visible on
the camera which is detecting the fluorescence, and it is easy to mistake the
signal received as coming from the surface vessels. However, even in the case
of the 415nm excitation light, less than 10% of the detected signal originated
from the vessel below the detector area.
Figs. 5.2, 5.3 and 5.4 show 3D renderings of the origin of detected
fluorescence generated using the camera illumination and detection scheme,
as generated by weighting each detected photon according to Eq. 2.6. The
total signal was then normalized to generate a 3D PDF of the signal using
1µm x 1µm bins. The simuation demonstrates that when a large area on
the surface is illuminated, the fluorescence signal collected at the surface can
originate not only from deeper in the tissue under the detector area, but also






Figure 5.2: 3D rendering of fluorescence signal distribution using wide-field









Figure 5.3: 3D rendering of fluorescence signal distribution using wide-field







Figure 5.4: 3D rendering of fluorescence signal distribution using wide-field
illumination with small area detection for 524nm excitation. The geometry is
a 800µm deep.
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is seen with source-detector separations. The renderings also provide a good
visual aid to explain the peaks in Fig. 5.1(a), 5.1(c) and 5.1(e). The peaks
at the surface correspond to the signal detected from the surface vasculature
under the entire illumination area, while the peaks at 40µm correspond to the
first vessel directly beneth the detector surface.
The results suggest that techniques that prioritize accurate imaging of
microvasculature should aim to focus the excitation light on the tissue of in-
terest. If the excitation light has a small NA (nearly collimated), then the
emitted light will represent vasculature at a number of different depths, de-
pendent on the distance between the surface and the first vessel the excitation
light meets. In Fig. 5.1(f), for example, the excitation photons scatter down to
40µm before encountering a blood vessel. Techniques that utilize depth selec-
tion independently of illumination would benefit from taking this observation
into consideration.
5.3 Conclusion
Three illumination and detection schemes used in fluorescence imaging
have been evaluated to determine the effect of imaging technique on the origin
of the collected signal. Targeted illumination schemes offer a more focused
signal distribution over wide field illumination. Using a camera with targeted
illumination in particular offers very strong localization of signal to the sur-
face vasculature, while wide-area detection can provide more depth-weighted
signals. Wide-area illumination with small area detection offers the greatest
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depth weighting of the three illumination and detection schemes that were
evaluated, but at the cost of including fluorescence from near the surface over
the entire illumination region.
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Chapter 6
Intra-vessel distribution of fluorescence
emission
The purpose of modeling fluorescence emission from a single vessel is
primarily to provide a more accurate picture regarding what happens when a
vessel is targeted with excitation light. The primary question is: if a surface
vessel is targeted, will the fluorescence signal returning from the tissue be
representative of that vessel? Though this is similar to the simulations done
in the previous chapter, with the targeted illumination schemes, here I look at
vessels that are on the surface of the tissue. Examples where this is the case
in the brain would be the dural vessels, which lie along the top of the surface
of the cerebrum.
6.1 Simulations
The objective of the single vessel geometry was to determine the pen-
etration of excitation light into underlying tissue, and thus to determine how
much of the captured signal can be attributed to the targeted vessel. As such,
the illumination area was a circle with a diameter that matched the diame-
ter of the vessel in each geometry. Vessel diameters of 25, 50, 75, 100, 150,
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and 200µm were used. Simulations were performed using 415nm, 524nm and
800nm illumination and a wide-field detector. Outside of the vessel, a 5%
volume fraction of vascularization was used so that a measure of the amount
of excitation light penetrating through the vessel could be easily measured.
6.2 Results and Discussion
Fig. 6.1 shows the results of single vessel geometry simulations at
524nm and 415nm illumination. Figs. 6.1(a) and 6.1(b) show a simulation
result when the vessel size was set to 100µm. The 3D distribution of the
signal, Id(x, y, z) was integrated along the length of the vessel to generate
the images in Figs. 6.1(a) and 6.1(b). A figure demonstrating single vessel
penetration of 800nm excitation light is not shown, as it visually appears
similar to the 524nm excitation case. Fig. 6.1(c) shows the fraction of the total
collected signal which originated inside the 100µm vessel at each of the three
excitation wavelengths. A targeted surface vessel with a diameter of 100µm,
for example, will produce a signal that is 100% representative of the vessel
fluorescence at 415nm, 80% representative of vessel fluorescence at 524nm,
and 50% representative of vessel fluorescence at 800nm.
At 415nm, seen in Fig. 6.1(c), the intra-vessel absorption was high
enough to completely prevent the excitation light from penetrating through to
deeper tissues. The absorption also prevented the excitation light from being
able to sample the entire vessel. This could effect measurements where an
average across the vessel diameter would provide a more accurate measurement
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of a given parameter than just the value near the vessel wall. The 524nm
illumination light was able to sample the entire vessel, but at smaller vessel
sizes the light also penetrated through the vessel and sampled a significant
amount of tissue outside the vessel in question. At 800nm, the results are
similar to the 524nm excitation case in Fig. 6.1(b), though as expected more
light is able to penetrate through the vessel. Note that while these results
demonstrate that using 415nm illumination can allow for strong emphasis of
surface vasculature in the targeted illumination scheme, Fig. 4.1 also suggests
that using this wavelength can result in emphasized surface vasculature in all































Figure 6.1: 100µm single vessel geometry with (a) 415nm targeted illumi-
nation and (b) 524nm targeted illumination. (c) Amount of detected signal
originating from inside the vessel as a function of vessel diameter.
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6.3 Conclusion
Here, I examined intra-vessel sampling and demonstrated that when
using an excitation wavelength that is strongly absorbed by blood, the col-
lected signal originates from only the top-surface of the targeted vessels. This
may need to be taken into account if using a lifetime imaging method that will
produce different results near the vessel walls–a wavelength which is absorbed




Conclusion and future work
In this work, several characteristics of fluorescence lifetime imaging in
the brain that have not to my knowledge been previously investigated were
studied.
First, it was shown that using a homogeneous geometry assumption
to approximate the depth-distribution of the collected fluorescence signal is
not an accurate method. A more complex model, involving both the differ-
ence in absorption at the excitation and emission wavelenths, as well as the
difference in absorption coefficients in the fluorescing region compared to the
non-fluorescing region is required to provide a more accurate picture of depth
penetration.
Additionally, three illumination and detection schemes used in fluores-
cence imaging were examined. Targeted illumination schemes offer a more
focused signal distribution over wide field illumination. Using a camera with
targeted illumination, in particular, offers very strong localization of signal to
the surface vasculature, while wide-area detection can provide more depth-
weighted signals. Wide-area illumination with small area detection offers the
greatest depth-weighting of the three illumination and detection schemes that
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were evaluated, but at the cost of including fluorescence from near-the-surface
over the entire illumination region.
Lastly, I examined intra-vessel sampling and demonstrated that when
using an excitation wavelength that is strongly absorbed by blood, the col-
lected signal originates from only the top-surface of the targeted vessels. This
may need to be taken into account if using a lifetime imaging method that will
produce different results near the vessel walls–a wavelength which is absorbed
by blood less may be more useful to provide a signal which is integrated across
the vessel diameter.
It is my hope that these results will aid design considerations when
building or purchasing an instrument to do intravascular fluorescence imaging.
In the future, I would like to perform a more intensive study of the flu-
orescence imaging dynamics by using arbitrary excitation and emission wave-
lengths. If the absorption properties of the constrast agent may be disregarded,
as is often the case in blood since it is such a strong absorber, then the optical
properties across the entire visible spectrum may be easily calculated. The dif-
ficulty, however, lies with the computational time required to run that many
simulations. One simulation would need to be run for each excitation wave-
length desired, though the emission wavelength would be changable through
postprocessing. As an example, to simulate the 800nm excitation case using
the camera scheme, over 10 billion photons were used to generate a conver-
gent fluorescence distribution. This simulation took approximately 6 days of
compute time to run.
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As computational time is the biggest limiter of a larger, more intensive
study of this kind, the next step would be to parallelize the fluorescence Monte
Carlo code. I plan to do this by implementing the algorithm in CUDA C,
which by moving the computation to a graphics processing unit (GPU), has
the potential to speed up the simulation run times several orders of magnitude.
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